Chronic HBV Infection Study: A study of Entecavir in Blacks/African Americans and Hispanics with chronic HBV infection.

HIV AIDS Clinical Trial: A Phase IIIB, Randomized, Trial of Open-label Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) with another PI in Combination with Double-Blind Comparison of two Nucleoside Reverse Transcriptase Inhibitor (NRTI) or a different NRTI in Antiretroviral-NaWve Subjects

HIV Infection (Initial Therapy): A phase III, randomized, open-label study of initial therapy for HIV-1 infection

HIV positive women: The purpose of this trial is to assess the immunogenicity, safety and tolerability of the quadrivalent human papillomavirus (HPV) recombinant vaccine (GARDASIL)directed against virus types 6, 11, 16, and 18.

HIV+ With Resistance to NRTIs and NNRTIs: A randomized strategy study for HIV-1-infected treatment-experienced subjects using the cPSS to select an effective regimen.

HIV/AIDS Clinical Trial: The study is being done at Rush University Medical Center in Chicago, Illinois, to learn if treating people during early HIV infection is beneficial. This study will evaluate how safe and effective a combination of anti-HIV drugs is for people with recently acquired HIV infection.

HIV/AIDS Promoting Maternal and Infant Survival Everywhere: The study at Rush University Medical Center in Chicago, Illinois, will screen and recruit pregnant or postpartum women on HIV meds for prevention of mother-to-child transmission of HIV.

Hepatitis C Study Using Antiviral Treatment: Study of a thrombopoietin receptor agonist, for 12 weeks in subjects with chronic hepatitis C-related thrombocytopenia who are potential candidates for antiviral treatment with pegylated interferon and ribavirin.

Plasma Donation for Influenza Antibodies: Plasma donation for influenza vaccinated or infected subjects

Policosonal for Dyslipidemia in HIV: Policosonal for dyslipidemia in HIV

Study Of TYZEKA with Compensated Chronic Hepatitis B Virus Infection: Study of TYZEKA in subjects of Black/African American or Hispanic/Latino origin with compensated chronic hepatitis B virus infection

Three Non-NNRTI-Sparing Antiretroviral Regimens: The purpose of this study is to compare the effectiveness and tolerability of three combination FDA-approved HIV medication regimens using Truvada (emtricitabine/tenofovir disoproxil fumarate) as a base.

Zoster Vaccine in HIV-Infected Adults: The purpose of this study is to determine if Zostavax, an FDA-approved vaccine, is safe, effective and tolerable for HIV-infected adults.